From: Personalized life expectancy and treatment benefit index of antiretroviral therapy
Par. | P8 | P9 | P10 | P11 | P12 | P13 | P14 | P15 |
---|---|---|---|---|---|---|---|---|
β λ | 108.12 | 109.99 | 127.17 | 107.15 | 174.51 | 112.38 | 139.62 | 113.85 |
β k | 1619.24 | 1444.27 | 1170.06 | 1626.31 | 1586.35 | 1490.67 | 1660.41 | 1576.88 |
α λ | 0.03 | 0.13 | 0.22 | 0.04 | 0.13 | 0.06 | 0.05 | 0.08 |
α k | 1.18 | 1.10 | 0.93 | 1.09 | 1.23 | 1.09 | 1.17 | 1.18 |
T m | 3128.4 | 4026.7 | 3701.9 | 3118.1 | 3254.5 | 3952.6 | 4300.6 | 3220.4 |
η | 0.99 | 0.87 | 0.95 | 0.94 | 0.96 | 0.93 | 0.93 | 0.95 |
τ 50 | 30 | 30.09 | 30.71 | 53.27 | 30.22 | 55.79 | 39.33 | 65.58 |
τ m | 21897 | 18753 | 21340 | 20003 | 21530 | 17541 | 21454 | 20267 |
q | 0.55 | 0.65 | 0.88 | 0.58 | 0.90 | 0.76 | 0.53 | 0.57 |
p | 4.65 | 4.98 | 3.25 | 2.61 | 3.30 | 2.11 | 3.04 | 2.18 |
\(\bar {\beta }_{k}\) | 746.11 | 619.94 | 961.22 | 189.82 | 1164.1 | 1321.1 | 814 | 772.8 |
\(\bar {\alpha }_{k}\) | 1.18 | 1.09 | 0.87 | 1.09 | 1.13 | 0.93 | 0.66 | 1.11 |
l | 0.92 | 0.86 | 0.84 | 0.92 | 0.83 | 0.93 | 0.81 | 0.93 |
T s | 2441.4 | 3498.6 | 3445.7 | 2472.7 | 2599.4 | 3002 | 3215.7 | 2569 |
T r | 4526.31 | 5048.56 | 4863.17 | 2872.21 | 3906.73 | 4790.24 | 4418.25 | 4498.8 |
T e | 7268.8 | 6339.7 | 6938.3 | 5054.7 | 6722.5 | 5473 | 6294.4 | 4708.4 |
T d | 24338.38 | 22251.46 | 24785.25 | 22476.19 | 24129.89 | 20542.58 | 24669.66 | 22835.56 |
B CD4 | 200 | 200 | 150 | – | 200 | 300 | 300 | 200 |